These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 32706089)

  • 1. Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.
    González-Pacheco H; Amezcua-Guerra LM; Sandoval J; Arias-Mendoza A
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7494-7496. PubMed ID: 32706089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.
    Schumann S; Kaiser A; Nicoletti F; Mangano K; Fagone P; van Wijk E; Yan Y; Schulz P; Ludescher B; Niedermaier M; von Wegerer J; Rauch P; Setz C; Schubert U; Brysch W
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment In COVID-19.
    Orienti I; Gentilomi GA; Farruggia G
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
    Jeon S; Ko M; Lee J; Choi I; Byun SY; Park S; Shum D; Kim S
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective: The Potential Effects of Naringenin in COVID-19.
    Alberca RW; Teixeira FME; Beserra DR; de Oliveira EA; Andrade MMS; Pietrobon AJ; Sato MN
    Front Immunol; 2020; 11():570919. PubMed ID: 33101291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
    Benani A; Ben Mkaddem S
    Front Immunol; 2020; 11():1841. PubMed ID: 32793246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory Drugs in the Management of SARS-CoV-2.
    Burrage DR; Koushesh S; Sofat N
    Front Immunol; 2020; 11():1844. PubMed ID: 32903555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19.
    Mrityunjaya M; Pavithra V; Neelam R; Janhavi P; Halami PM; Ravindra PV
    Front Immunol; 2020; 11():570122. PubMed ID: 33117359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review.
    Santos J; Brierley S; Gandhi MJ; Cohen MA; Moschella PC; Declan ABL
    Viruses; 2020 Jun; 12(7):. PubMed ID: 32629804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothesis: Pentoxifylline is a potential cytokine modulator therapeutic in COVID-19 patients.
    Hendry BM; Stafford N; Arnold AD; Sangwaiya A; Manglam V; Rosen SD; Arnold J
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00631. PubMed ID: 32715661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19).
    Yuan S; Chan CC; Chik KK; Tsang JO; Liang R; Cao J; Tang K; Cai JP; Ye ZW; Yin F; To KK; Chu H; Jin DY; Hung IF; Yuen KY; Chan JF
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32532085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs.
    Tufan A; Avanoğlu Güler A; Matucci-Cerinic M
    Turk J Med Sci; 2020 Apr; 50(SI-1):620-632. PubMed ID: 32299202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15 immunotherapy is a viable strategy for COVID-19.
    Kandikattu HK; Venkateshaiah SU; Kumar S; Mishra A
    Cytokine Growth Factor Rev; 2020 Aug; 54():24-31. PubMed ID: 32536564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GRL-0920, an Indole Chloropyridinyl Ester, Completely Blocks SARS-CoV-2 Infection.
    Hattori SI; Higshi-Kuwata N; Raghavaiah J; Das D; Bulut H; Davis DA; Takamatsu Y; Matsuda K; Takamune N; Kishimoto N; Okamura T; Misumi S; Yarchoan R; Maeda K; Ghosh AK; Mitsuya H
    mBio; 2020 Aug; 11(4):. PubMed ID: 32820005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.
    Dalamaga M; Karampela I; Mantzoros CS
    Metabolism; 2020 Aug; 109():154282. PubMed ID: 32497535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications.
    Pelaia C; Tinello C; Vatrella A; De Sarro G; Pelaia G
    Ther Adv Respir Dis; 2020; 14():1753466620933508. PubMed ID: 32539627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.